Your browser doesn't support javascript.
loading
A retrospective study of 2 or 3 mg/kg/day propranolol for infantile hemangioma.
Goto, Kohei; Ozeki, Michio; Yasue, Shiho; Endo, Saori; Fukao, Toshiyuki.
Affiliation
  • Goto K; Department of Pediatrics, Gifu University Graduate School of Medicine, Gifu University, Gifu, Japan.
  • Ozeki M; Department of Pediatrics, Gifu University Graduate School of Medicine, Gifu University, Gifu, Japan.
  • Yasue S; Department of Pediatrics, Gifu University Graduate School of Medicine, Gifu University, Gifu, Japan.
  • Endo S; Department of Pediatrics, Gifu University Graduate School of Medicine, Gifu University, Gifu, Japan.
  • Fukao T; Department of Pediatrics, Gifu University Graduate School of Medicine, Gifu University, Gifu, Japan.
Pediatr Int ; 62(6): 751-753, 2020 06.
Article in En | MEDLINE | ID: mdl-32490577

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Propranolol / Soft Tissue Neoplasms / Adrenergic beta-Antagonists / Hemangioma Type of study: Observational_studies Limits: Female / Humans / Infant / Male Language: En Journal: Pediatr Int Journal subject: PEDIATRIA Year: 2020 Document type: Article Affiliation country: Japón

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Propranolol / Soft Tissue Neoplasms / Adrenergic beta-Antagonists / Hemangioma Type of study: Observational_studies Limits: Female / Humans / Infant / Male Language: En Journal: Pediatr Int Journal subject: PEDIATRIA Year: 2020 Document type: Article Affiliation country: Japón